Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis

• Published in: BMJ open gastroenterology Vol. 8; no. 1; p. e000662
• Main Authors: Yagi, Sen, Furukawa, Shinya, Shiraishi, Kana, Hashimoto, Yu, Tange, Kazuhiro, Mori, Kenichirou, Ninomiya, Tomoyuki, Suzuki, Seiyuu, Shibata, Naozumi, Murakami, Hidehiro, Ohashi, Katsuhisa, Hasebe, Aki, Tomida, Hideomi, Yamamoto, Yasunori, Takeshita, Eiji, Ikeda, Yoshio, Hiasa, Yoichi
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 07.06.2021; BMJ Publishing Group
• Subjects: Biomarkers; Blood tests; Body mass index; Clinical outcomes; Colonoscopy; Endoscopy; Epidemiology; Erythema; Inflammatory bowel disease; Monoclonal antibodies; Patients; Proteins; Software; Tumor necrosis factor-TNF

ObjectiveSerum albumin is used as a marker of acute inflammation. Several studies have addressed the association between serum albumin and clinical outcome in patients with ulcerative colitis (UC). While mucosal healing (MH) has been indicated as the therapeutic goal for UC, the association between...